Influenza News and Research

Latest Influenza News and Research

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Researchers assessed the knowledge, attitudes, and practices (KAP) of healthcare workers (HCWs) towards monkeypox (MPX) in Italy.

29 Jul 2022

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

In severe Covid-19 patients, the metabolism produces insufficient amounts of certain energy-rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in the immune system in order to fight the virus effectively.

28 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

Researchers presented a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants of interest and variants of concern in a viral multiple sequence alignment.

28 Jul 2022

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Researchers estimated the years of life lost during the COVID-19 pandemic in the United States.

28 Jul 2022

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Researchers depicted the correlations between receptor-binding domain (RBD)-selective proliferative memory CD4 T cells and neutralizing antibodies in COVID-19 vaccinees and convalescent patients.

27 Jul 2022

Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

In a new study, researchers have focused on evaluating small-for-gestational-age rates and preterm birth in a large cohort.

27 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

In a new study, researchers developed a maximum likelihood model to capture severe acute respiratory syndrome coronavirus 2 evolutionary dynamics in multiple geographical regions.

26 Jul 2022

Tunneling nanotubes can assist SARS-CoV-2 propagation

A new study found that tunneling nanotubes (TNTs) offer a pathway for SARS-CoV-2 neuronal spreading.

26 Jul 2022

Long-COVID is relatively infrequent, but still poses a threat

A new study suggests that long COVID complaints may not be common among COVID-19 patients as compared to the general population.

25 Jul 2022

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

Researchers at the Texas A&M University School of Public Health have developed a new COVID-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have COVID-19.

25 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

A new study has explored the entrapment efficacy of CTB-ACE2 chewing gum against different strains of SARS-CoV-2.

20 Jul 2022

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

Outliers in the number of cases of influenza-like illness (ILI) that tested negative for influenza were present in global influenza surveillance networks early in the COVID-19 pandemic, an average of 13.3 weeks before the first reported COVID-19 peaks in 16 of the 28 countries included in a new study publishing July 19th in PLOS Medicine by Natalie Cobb of University of Washington, US, and colleagues.

20 Jul 2022

Potential mRNA vaccines for influenza

Scientists discuss the benefits of shifting the global influenza vaccination system to a mRNA-based platform,

19 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

Influenza News and Research

Latest Influenza News and Research

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

How has vaccination shaped the global evolutionary trajectory of SARS-CoV-2?

Tunneling nanotubes can assist SARS-CoV-2 propagation

Long-COVID is relatively infrequent, but still poses a threat

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

Potential mRNA vaccines for influenza

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in